Absolutely yes. This is a pure immunotherapy drug. All the therapeutic effect u see starting from progress to overall survival is cd8 cells activity and general immune response killing the tumor. I m glad to see in last pr they start talking about vb111 curing cancer. It's about time they should have done it in the asco. In 2 patients the cancer was cured after 1 dose of vb111 - again it's the immune response .
News 
Market Data 
Discover 
AI
